AI revolutionizes cancer research with advanced tools

Significant advancements in understanding the molecular and cellular mechanisms of tumor progression have been made, yet challenges remain.

Engineered NK cells with IL-21 show strong antitumor activity against glioblastoma

Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like cells (GSCs) both in vitro and in vivo,

August 12, 2024

Trump surgeon general admits Trump White House made mistakes during Covid

The Trump administration made some serious missteps during the coronavirus pandemic, Trump’s top doctor Jerome Adams admits. But he says we still haven’t learned from

September 7, 2023

Johnson & Johnson reports 6.3% rise in Q2 2023 sales

In the pharmaceutical segment of Johnson & Johnson, a 3.1% rise in sales to $13.73bn in Q2 2023 was reported. Credit: Michael Vi / Shutterstock.com.

July 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.